Primerdesign

26/11/2021

We can confirm, all our primary assays, targeting ORF1ab, S, M and nsp16 genes will detect the B.1.1.529 . We remain dedicated and at the forefront in our response to the constantly changing global pandemic.

Scientists are closely watching a new variant circulating in South Africa - but there are few clear answers.

26/11/2021

We are delighted to announce that our genesig® test has been approved and added to the CTDA register. Please read about it in our latest RNS, issued today: https://bit.ly/3cPoF6h

17/11/2021

Don't forget to visit us at Stand B111 at the Brussels Expo today. Come meet our team to discuss your needs and check out our unit.

15/11/2021

All ready for ! Come meet our expert, Sagar, to discuss your needs. See you there!

27/09/2021

This year we have already started to see an increase in some , most prevalently thought to be infecting younger individuals a lot earlier than anticipated. Click here to read more: https://bit.ly/3kRcoSs

21/09/2021

With just one week to go until , we’re looking forward to getting to meet you all face to face finally. Join us September 28-30, booth 3130, for a chat – we can’t wait to see you there!

13/09/2021

Read today's RNS for information on how to register and vote at the 2021 AGM: https://bit.ly/3htmKqF

11/09/2021

Novacyt has been making a difference to millions of people’s lives and continues to be at the forefront of testing during the pandemic. This success has allowed us to give back to the community through ’s Committee.

31/08/2021

Our incredibly talented bioinformaticians have played a pivotal role in identifying future threats throughout this .

19/08/2021

Our investor event is now available to view! So, if you missed it or want to watch it through again, click here to view it today: https://bit.ly/3ggMh5V